kadmon.comDeveloping transformative therapies for immune disorders, fibrotic diseases and cancer - Kadmon Hold

kadmon.com Profile

kadmon.com is a domain that was created on 2002-04-10,making it 23 years ago. It has several subdomains, such as investors.kadmon.com , among others.

Discover kadmon.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

kadmon.com Information

HomePage size: 43.603 KB
Page Load Time: 0.129633 Seconds
Website IP Address: 64.207.154.158

kadmon.com Similar Website

Clinical Viewpoints CME on Chronic Immune Thrombocytopenia itp.clinicalviewpointscme.com
Dynamic Media Help – Music for Business \| Music On Hold \| Message On Hold help.dynamicmediamusic.com
Home - 2023 Targeted Therapies of Lung Cancer Meeting ttlc2023.iaslc.org
IMMUNE MATTERS – La Jolla Institute mag.lji.org
Alpine Immune - Investor Relations ir.alpineimmunesciences.com
Ayurvedic Doctor - Ask Dr Charak for Panchkarma Therapies, Health Diseases & Conditions ask.charak.com
MD Anderson Cancer Center: Cancer Treatment & Cancer Research Hospital \| MD Anderson Cancer Center www3.mdanderson.org
Dr. David Wheeler's natural supplements for the immune system secure.slateboard.com
Cancer Epigenetics \| A journal of the Cancer Epigenetics Society \| Cancer Epigenetics ce.b2sg.org
Movement Disorders & Neurorestoration Program NORMAN FIXEL INSTITUTE for NEUROLOGICAL DISEASES » U movementdisorders.ufhealth.org
Investors - Kadmon Holdings, Inc. investors.kadmon.com
Marasco Lab - Treatment of Emerging Infectious Diseases and Cancer - Home marascolab.dana-farber.org
4Life - The Immune System Company® malaysia.4life.com
Easy on Hold Knowledgebase - The Music On Hold learn.easyonhold.com

kadmon.com PopUrls

united states securities and exchange commission https://investors.kadmon.com/static-files/ce2e72ff-a0e2-4ac7-9539-4070c106bd27
Kadmon https://servicedesk.kadmon.com/

kadmon.com DNS

MX kadmon.com. 900 IN MX 10 de-smtp-inbound-1.mimecast.com.
NS kadmon.com. 900 IN NS ns1.sanofi-synthelabo.com.
TXT kadmon.com. 900 IN TXT MS=B1BCBBDEB0B6561299B6A0DBEB038DE61F6E6E51
SOA kadmon.com. 900 IN SOA ns1.sanofi-synthelabo.com. gtly-domtech.sanofi.com. 2016030761 28800 14400 3600000 900

kadmon.com Httpheader

Server: nginx
Date: Sun, 20 Dec 2020 15:30:18 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 6902
Connection: keep-alive
Last-Modified: Wed, 16 Dec 2020 19:54:27 GMT
Accept-Ranges: bytes
Vary: Accept-Encoding
Content-Encoding: gzip
Cache-Control: max-age=0, no-cache, no-store, must-revalidate
Pragma: no-cache
Expires: Mon, 29 Oct 1923 20:30:00 GMT
X-Powered-By: PleskLin

kadmon.com Meta Info

charset="utf-8"/
content="IE=edge" http-equiv="X-UA-Compatible"/
content="width=device-width, initial-scale=1" name="viewport"/
content="josh@comocreative.com" name="author"/
content="7 days" name="revisit-after"/
content="noindex,follow" name="robots"
content="en_US" property="og:locale"
content="website" property="og:type"
content="Developing transformative therapies for immune disorders, fibrotic diseases and cancer - Kadmon Holdings, Inc." property="og:title"
content="https://kadmon.com/" property="og:url"/
content="Kadmon Holdings, Inc." property="og:site_name"/
content="https://kadmon.com/wp-content/uploads/bg-home-top-min.jpg" property="og:image"/
content="https://kadmon.com/wp-content/uploads/bg-home-top-min.jpg" property="og:image:secure_url"/
content="1920" property="og:image:width"/
content="1080" property="og:image:height"/
content="summary_large_image" name="twitter:card"/
content="Developing transformative therapies for immune disorders, fibrotic diseases and cancer - Kadmon Holdings, Inc." name="twitter:title"/
content="https://kadmon.com/wp-content/uploads/bg-home-top-min.jpg" name="twitter:image"/
content="https://kadmon.com/wp-content/uploads/favicon-min.png" name="msapplication-TileImage"/

kadmon.com Ip Information

Ip Country: United States
City Name: Ashburn
Latitude: 39.0469
Longitude: -77.4903

kadmon.com Html To Plain Text

Toggle Navigation Search:Our Company Leadership Board of Directors Kadmon Commitment Contact Clinical Pipeline About Belumosudil Belumosudil in cGVHD Belumosudil in Systemic Sclerosis About KD033 Clinical Trials Science Preclinical Pipeline Biologics Monoclonal Antibody Discovery Platform IL-15 Platform Small Molecules Structure-Based Drug Design Publications and Posters Products Investors Investors Home News & Events Press Releases Presentations & Events Stock Information Stock Quote & Chart Analyst Coverage Historic Price Lookup Financials & Filings Corporate Governance Documents & Charters Leadership Board of Directors Investor Resources Investor/Media FAQs Contact Us Email Alerts Careers Search: Contact Developing transformative therapies for immune disorders, fibrotic diseases and cancerKadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. We are developing treatments for immune and fibrotic diseases as well as immuno-oncology therapies. Learn More News December 6, 2020 Kadmon Announces 12 Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting November 30, 2020 Kadmon Announces FDA Acceptance of NDA for Belumosudil in Patients With Chronic Graft-Versus-Host Disease November 24, 2020 Kadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual Meeting Belumosudil We have a deep understanding of the pathways involved in inflammation and fibrosis. Our late-stage product candidate, Belumosudil, is an inhibitor of ROCK2, a signaling pathway that modulates key inflammatory and fibrotic processes. A pivotal study of belumosudil is underway in patients with chronic graft-versus-host disease (cGVHD). A Phase 2 clinical trial of belumosudil is also underway in patients with systemic sclerosis (SSc). Read More Our Science Biologics IL-15 Platform Learn More Biologics Monoclonal Antibody Discovery Platform Learn More Small Molecule Structure-Based Drug Design Learn More 450 East 29th Street New York, New York 10016 55 Cambridge Parkway, Suite 300E Cambridge, Massachusetts 02142 119 Commonwealth Drive Warrendale, Pennsylvania 15086 Site Map Privacy Policy Terms of Use California Compliance © 2020 Kadmon Holdings, Inc.. All Rights...

kadmon.com Whois

Domain Name: KADMON.COM Registry Domain ID: 85469035_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-04-06T05:14:04Z Creation Date: 2002-04-10T20:52:17Z Registry Expiry Date: 2025-04-10T20:52:17Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:59:02Z <<<